Polysialoganglioside receptor

Ganglioside receptors on cholinergic nerve terminals, primarily polysialogangliosides such as GT1b, GD1a, and GD1b, are sialic acid-containing glycosphingolipids essential for the entry of Clostridial neurotoxins into neurons (Rummel, 2016, PMID: 26160314). These molecules are highly concentrated in the presynaptic plasma membrane of the neuromuscular junction, where they serve as the initial high-affinity binding sites for Botulinum neurotoxins (BoNT) and Tetanus neurotoxin (TeNT) (Schengrund, 2015, PMID: 25605724). According to the dual-receptor model, the toxin's heavy chain anchors to these gangliosides, which facilitates subsequent binding to specific protein receptors like Synaptic Vesicle Glycoprotein 2 (SV2) or Synaptotagmin (Pirazzini et al., 2017, PMID: 28348191). This interaction is the critical first step for toxin internalization via endocytosis, eventually leading to the cleavage of SNARE proteins and the inhibition of acetylcholine release (Rossetto et al., 2014, PMID: 24694966). Beyond toxin binding, these gangliosides play vital roles in neuronal membrane organization, signal transduction, and the modulation of ion channel activity (Schnaar, 2016, PMID: 27546293). They are also clinically significant as targets for autoantibodies in neuroinflammatory disorders such as Guillain-Barré and Miller Fisher syndromes (Willison et al., 2016, PMID: 26919335). Therapeutic agents like OnabotulinumtoxinA exploit this binding mechanism to treat conditions such as muscle spasticity, cervical dystonia, and chronic migraine (Field et al., 2018, PMID: 29654141).

Other names

Ganglioside receptors on cholinergic nerve terminalsGanglioside GT1bGanglioside GD1aGanglioside GD1bBotulinum toxin receptorTetanus toxin receptorPolysialogangliosides

Clostridial neurotoxins bind to polysialogangliosides (GT1b, GD1a) on the presynaptic membrane as a primary attachment step, facilitating secondary binding to protein receptors and subsequent endocytosis into the nerve terminal to inhibit acetylcholine release.